Tricyclic antidepressants and the incidence of certain cancers: A study using the GPRD

British Journal of Cancer

Volumn 104, Issue 1, 2011, Pages 193-197

  Walker, A J ^a   Card, T ^a,b,c   Bates, T E ^d,e   Muir, K ^f  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b KING S MILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF LINCOLN   (United Kingdom)

^e BioCity Nottingham   (United Kingdom)

^f UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

colorectal cancer; glioma; GPRD; tricyclic antidepressants

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DEPRESSION; DOSE RESPONSE; FEMALE; GENDER; GENERAL PRACTICE; GLIOMA; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK; SMOKING;

AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78650882584     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605996     Document Type: Article

References (26)

1. Arimochi H, Morita K (2006) Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 541: 17-23
2. Beaney RP, Gullan RW, Pilkington GJ (2005) Therapeutic potential of antidepressants in malignant glioma: clinical experience with clomipramine. J Clin Oncol (Meeting Abstracts) 23: 1535
3. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302: 649-658
4. Cotterchio M, Kreiger N, Darlington G, Steingart A (2000) Antidepressant medication use and breast cancer risk. Am J Epidemiol 151: 951-957
5. Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M, Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10: 501-507
6. Daley E, Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ, Bates TE, Daley E,Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ, Bates TE (2005) Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun 328: 623-632
7. Fombonne E, Heavey L, Smeeth L, Rodrigues LC, Cook C, Smith PG, Meng L, Hall AJ, Fombonne E, Heavey L, Smeeth L, Rodrigues LC, Cook C, Smith PG, Meng L, Hall AJ (2004) Validation of the diagnosis of autism in general practitioner records. BMC Public Health 4: 5
8. Fulton-Kehoe D, Rossing MA, Rutter C, Mandelson MT, Weiss NS (2006) Use of antidepressant medications in relation to the incidence of breast cancer. Br J Cancer 94: 1071-1078
9. Gonzalez-Perez A, Garcia Rodriguez LA (2005) Breast cancer risk among users of antidepressant medications. Epidemiology 16: 101-105
10. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69: 4-14
11. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302: 766-768
12. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H, Jick SS, Kaye JA, Vasilakis- Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H (2003) Validity of the general practice research database. Pharmacotherapy 23: 686-689
13. Kaye JA, Jick H (2004) Statin use and cancer risk in the General Practice Research Database. Br J Cancer 90: 635-637
14. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A (2005) Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27: 29-42
15. Merry S, Hamilton TG, Flanigan P, Freshney RI, Kaye SB (1991) Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine. Eur J Cancer 27: 31-34
16. Patricia FC, Brian LS, Lynn R (2009) Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf 18: 1111-1114
17. Pommerenke EW, Volm M (1995) Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo 9: 99-101
18. Tamim HM, Mahmud S, Hanley JA, Boivin JF, Stang MR, Collet JP (2007) Antidepressants and risk of prostate cancer: a nested case-control study. Prostate Cancer Prostatic Dis 11: 53-60
19. Toh S, Garc?́a Rodr?́guez L, Hernández-D?́az S (2007) Use of antidepressants and risk of lung cancer. Cancer Causes and Control 18: 1055-1064
20. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine. J Pharmacobiodyn 6: 145-147
21. van Schaik N, Graf U (1991) Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat Res 260: 99-104
22. Weinbach EC, Costa JL, Nelson BD, Claggett CE, Hundal T, Bradley D, Morris SJ (1986) Effects of tricyclic antidepressant drugs on energylinked reactions in mitochondria. Biochem Pharmacol 35: 1445-1451
23. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA (2009) Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf 18: 284-290
24. Xia Z, Bergstrand A, DePierre JW, Nassberger L (1999) The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 13: 338-347
25. Xu W, Tamim H, Shapiro S, Stang MR, Collet J-P (2006) Use of antidepressants and risk of colorectal cancer: a nested case-control study.[see comment]. Lancet Oncol 7: 301-308
26. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H (2009) Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. Cancer 115: 5662-5671